-0.5 C
New York
Wednesday, February 21, 2024

23andMe is low on cash and its stock is worth pennies. The CEO wants another chance

Just three years ago, DNA testing company 23andMe was the golden child of Wall Street and Silicon Valley. Today, the firm is at risk of being delisted from the Nasdaq.

But 23andMe’s CEO, Anne Wojcicki, tells CNN that Wall Street shouldn’t count her out yet.

Continue here >

This post was originally published on this site

Subscribe
Notify of
0 Comments
Inline Feedbacks
View all comments

Stay Connected

157,598FansLike
396,312FollowersFollow
2,280SubscribersSubscribe

Latest Articles

0
Would love your thoughts, please comment.x
()
x